The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Athira Pharma Inc shares valued at $1 were purchased by Mark James Litton on Sep 05 ’24. At $0.00 per share, Mark James Litton acquired 5,032 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Gengos Andrew sold 1,272 shares, netting a total of over 720 in proceeds. Following the sale of shares at $0.57 each, the insider now holds 97,532 shares.
Before that, Lenington Rachel had sold 2,525 shares from its account. In a trade valued at $1,429, the COO and CDO traded Athira Pharma Inc shares for $0.57 each. Upon closing the transaction, the insider’s holdings decreased to 2,525 shares, worth approximately $10017.6.
As published in a research note from Mizuho on September 19, 2024, Athira Pharma Inc [ATHA] has been rated down from an Outperform to a Neutral and the price target has been revised to $0.50 from $5. Analysts at Rodman & Renshaw downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early September. As of September 04, 2024, JMP Securities has decreased its “Mkt outperform” rating to a “Mkt perform” for ATHA. Earlier on September 04, 2024, BTIG Research downgraded its rating. Their new recommendation was “a Neutral” for ATHA stock which previously was a “a Buy”.
Analyzing ATHA Stock Performance
During the last five days, there has been a surge of approximately 4.69%. Over the course of the year, Athira Pharma Inc shares have dropped approximately -80.42%. Nevertheless, trading volume fell to 0.73 million shares from 0.33 million shares the previous day.
Support And Resistance Levels for Athira Pharma Inc (ATHA)
RSI (Relative Strength Index) is 33.21 on the 14-day chart, showing neutral technical sentiment.
